Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Mattheus

Consistent Cardiovascular (CV) Benefit of Empagliflozin Over the Spectrum of CV Risk Factor Control in EMPA-REG OUTCOME

Metabolism: Clinical and Experimental

English

Empagliflozin (Empa) Reduces Heart Failure Outcomes Irrespective of Blood Pressure (Bp), Low Density Lipoprotein Cholesterol (Ldl-C) and Hba1c Control

Canadian Journal of Cardiology

Cardiovascular Medicine

English